Hanmi Pharm wins US patent for amlodipine camsylate
Published: 2004-11-17 06:57:00
Updated: 2004-11-17 06:57:00
Hanmi Pharm said it has acquired an U.S. patent for the manufacturing process of amlodipine camsylate with better combination of properties in terms of photo stability and purity, soon after the obtainment of the Korea patent in October.
The company invested three billion won for the developme...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
